Empirical antifungal therapy in treating febrile neutropenic patients

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
J R Wingard

Abstract

Persistent or recurrent unexplained fever in neutropenic patients receiving antibiotics can be caused by invasive fungal infections, which are often difficult to diagnose. Early trials of empirical antifungal therapy with amphotericin B deoxycholate (AmB) documented reductions in the frequency of and the morbidity and mortality associated with invasive fungal infections. Because of AmB's infusional and renal toxicities, subsequent trials used newer, less toxic agents, such as the lipid formulations of AmB, the extended-spectrum azoles, and, more recently, the echinocandins. To date, alternatives to AmB have shown less toxicity, but improved efficacy has been less clear. Overall, empirical antifungal therapy can help prevent the morbidity associated with many fungal infections, eliminate concerns about diagnostic pitfalls, and prevent breakthrough undetected infections. However, its potential shortcomings are overtreatment, toxicity, and increased treatment-related costs when treatment is given to persons not needing it. Newer diagnostic tools are needed to target those most in need of antifungal therapy.

References

Aug 26, 1998·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·M H WhiteC B Miller
Nov 14, 2000·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·J R WingardUNKNOWN L Amph/ABLC Collaborative Study Group
Jan 3, 2001·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·D CaillotH Guy
Oct 12, 2001·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·M T LinW L Chen
Jan 25, 2002·The New England Journal of Medicine·Thomas J WalshUNKNOWN National Institute of Allergy and Infectious Diseases Mycoses Study Group
Apr 8, 2003·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·John E BennettPaul Verweij
Apr 8, 2003·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·John E BennettClaudio Viscoli

❮ Previous
Next ❯

Citations

Dec 8, 2004·Der Internist·X SchielH Ostermann
Nov 22, 2007·Wiener medizinische Wochenschrift·Philipp StaberPeter Neumeister
Jun 8, 2012·International Journal of Clinical Pharmacy·Ehud HorwitzAllon E Moses
Jun 1, 2006·Current Hematologic Malignancy Reports·Melissa Corey
Dec 20, 2008·Current Infectious Disease Reports·Melissa Corey
Jul 14, 2004·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Juan J Picazo
Jul 14, 2004·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Kenneth V I Rolston
Dec 7, 2006·BMC Infectious Diseases·Donghui T YuDavid W Bates
Jul 29, 2006·Annals of Clinical Microbiology and Antimicrobials·Ridvan AliAhmet Tunali
Aug 28, 2010·Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy·Mao HagiharaHiroshige Mikamo
Dec 7, 2007·Infectious Disease Clinics of North America·Anastasia Antoniadou, Helen Giamarellou
Mar 10, 2007·International Journal of Antimicrobial Agents·Abhijit M Bal, Ian M Gould
Mar 6, 2007·Best Practice & Research. Clinical Haematology·John R Wingard
Aug 4, 2009·Journal of Clinical Pharmacy and Therapeutics·D-G LeeW-S Shin
Jan 10, 2006·British Journal of Haematology·Rodrigo Martino, Claudio Viscoli
Apr 1, 2011·Pharmacotherapy·Jenna J FerraraJason C Gallagher
Nov 9, 2005·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·M BonadioM Petrini
Jul 3, 2013·Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy·Hideo KohTohru Masaoka
Jul 15, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Rodrigo D PortugalMarcio Nucci
Mar 26, 2014·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Yonghua LiXiaojun Huang
Nov 25, 2004·Hematology·John R WingardGeorge B McDonald
Jul 1, 2011·The Korean Journal of Internal Medicine·Dong-Gun LeeJung-Hyun Choi

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Related Papers

The New England Journal of Medicine
Thomas J WalshNational Institute of Allergy and Infectious Diseases Mycoses Study Group
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
J E BennettPaul Verweij
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
A ComettaInternational Antimicrobial Therapy Group of the European Organization for Research Treatment of Cancer
© 2022 Meta ULC. All rights reserved